Professor and Chief of Pediatric Neurology, University of Tennessee Health Science Center

Le Bonheur Chair in Pediatric Neurology, University of Tennessee Health Science Center

Director, Neuroscience Institute and Le Bonheur Comprehensive Epilepsy Program, Le Bonheur Children's Hospital

Patient Care Emphasis

Epilepsy, Clinical Neurophysiology, Pediatric Neurology, Tuberous Sclerosis Complex, Dravet Syndrome, Magnetoencephalography (MEG)

Medical School

University of Oklahoma

Board Certification

American Board of Pediatrics
American Board of Psychiatry and Neurology, Special Competencies in Child Neurology and Clinical Neurophysiology


University of Oklahoma - Pediatrics


University of Oklahoma - Pediatrics


Children's Memorial Hospital, Northwestern University - Child Neurology | Medical College of Georgia - EEG/Epilepsy

Awards and Honors

Recognized in US News & World Report Top Doctors, Recognized in Best Doctors in America, Memphis Business Journal Health Care Heroes finalist - 2006, National Tuberous Sclerosis Association Clinical Care Advisory Board, International Epilepsy Committee Executive Committee Member, Epilepsy.com Professional Advisory Board Member, Citizens United for Research in Epilepsy (CURE) Scientific Advisory Board, 2007 - Selected for the 61st Edition of "Who's Who in America, 2006 - Selected for the 23rd Edition of "Who's Who in the World, 2005 - Selected for the 8th Edition of "Who's Who in Science and Engineering, 2004 - Selected for the 5th Edition of "Who's Who in Medicine and Healthcare, 2003 - Selected for the 8th Edition of "Best Doctors in America, Current Research: Childhood Absence Epilepsy RX, PK-PD, Pharmacogenetics, NIH Grant, Levetiracetam Prophylaxis Trial in Newly Diagnosed Brain Tumors, UCB Pharma, Inc., The Safety of Intravenous Levetiracetam, Shainberg Neuroscience Research Fund, Study of the Safety and Efficacy of Levetiracetam in Children with Partial-Onset Seizures, UCB Phama, Inc., Study to Evaluate the Cognitive and Neurophychological Effects of Levetiracetam as Adjunctive Treatment in Children 4-16 years old with Partial Seizures, UCB Pharma, Inc., Genetics of Epilepsy Research Study, Shainberg Neuroscience Research Fund

Professional Memberships

American Academy of Neurology, American Academy of Pediatrics and section of Child Neurology, Epilepsy Foundation of America, American Epilepsy Association (ex-officio member), International Epilepsy Consortium, National Tuberous Sclerosis Association, The Charlie Foundation to Help Cure Pediatric Epilepsy and Epilepsy.com